# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001104659-26-002688
Filing Date
2026-01-12
Accepted
2026-01-12 06:45:55
Documents
43
Period of Report
2026-01-12
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | tm262894d1_8k.htm iXBRL | 8-K | 31588
2 | EXHIBIT 99.1 | tm262894d1_ex99-1.htm | EX-99.1 | 65538
3 | EXHIBIT 99.2 | tm262894d1_ex99-2.htm | EX-99.2 | 14736
4 | GRAPHIC | tm262894d1_ex99-1img001.jpg | GRAPHIC | 57907
5 | GRAPHIC | tm262894d1_ex99-1img002.jpg | GRAPHIC | 358823
6 | GRAPHIC | tm262894d1_ex99-1img003.jpg | GRAPHIC | 274412
7 | GRAPHIC | tm262894d1_ex99-1img004.jpg | GRAPHIC | 170380
8 | GRAPHIC | tm262894d1_ex99-1img005.jpg | GRAPHIC | 145925
9 | GRAPHIC | tm262894d1_ex99-1img006.jpg | GRAPHIC | 173079
10 | GRAPHIC | tm262894d1_ex99-1img007.jpg | GRAPHIC | 193943
11 | GRAPHIC | tm262894d1_ex99-1img008.jpg | GRAPHIC | 203346
12 | GRAPHIC | tm262894d1_ex99-1img009.jpg | GRAPHIC | 205159
13 | GRAPHIC | tm262894d1_ex99-1img010.jpg | GRAPHIC | 185478
14 | GRAPHIC | tm262894d1_ex99-1img011.jpg | GRAPHIC | 218975
15 | GRAPHIC | tm262894d1_ex99-1img012.jpg | GRAPHIC | 197756
16 | GRAPHIC | tm262894d1_ex99-1img013.jpg | GRAPHIC | 92214
17 | GRAPHIC | tm262894d1_ex99-1img014.jpg | GRAPHIC | 209327
18 | GRAPHIC | tm262894d1_ex99-1img015.jpg | GRAPHIC | 187465
19 | GRAPHIC | tm262894d1_ex99-1img016.jpg | GRAPHIC | 236294
20 | GRAPHIC | tm262894d1_ex99-1img017.jpg | GRAPHIC | 206084
21 | GRAPHIC | tm262894d1_ex99-1img018.jpg | GRAPHIC | 194039
22 | GRAPHIC | tm262894d1_ex99-1img019.jpg | GRAPHIC | 203667
23 | GRAPHIC | tm262894d1_ex99-1img020.jpg | GRAPHIC | 207209
24 | GRAPHIC | tm262894d1_ex99-1img021.jpg | GRAPHIC | 92251
25 | GRAPHIC | tm262894d1_ex99-1img022.jpg | GRAPHIC | 228354
26 | GRAPHIC | tm262894d1_ex99-1img023.jpg | GRAPHIC | 186423
27 | GRAPHIC | tm262894d1_ex99-1img024.jpg | GRAPHIC | 230088
28 | GRAPHIC | tm262894d1_ex99-1img025.jpg | GRAPHIC | 194439
29 | GRAPHIC | tm262894d1_ex99-1img026.jpg | GRAPHIC | 201943
30 | GRAPHIC | tm262894d1_ex99-1img027.jpg | GRAPHIC | 190917
31 | GRAPHIC | tm262894d1_ex99-1img028.jpg | GRAPHIC | 181826
35 | GRAPHIC | tm262894d1_ex99-2img001.jpg | GRAPHIC | 3239
| Complete submission text file | 0001104659-26-002688.txt |  | 7784859

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
32 | XBRL TAXONOMY EXTENSION SCHEMA | zura-20260112.xsd | EX-101.SCH | 3011
33 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | zura-20260112_lab.xml | EX-101.LAB | 34239
34 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | zura-20260112_pre.xml | EX-101.PRE | 22356
45 | EXTRACTED XBRL INSTANCE DOCUMENT | tm262894d1_8k_htm.xml | XML | 3332

Mailing Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037 858-247-0520
Zura Bio Ltd (Filer) CIK: 0001855644 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40598 | Film No.: 26524602
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)